India, April 29 -- 29th April 2025 | Bengaluru, India, Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), has quietly grown into one of India's most pressing public health challenges.

Today, nearly 4 in 10 Indian adults are living with MASLD, a condition intricately linked to metabolic disorders like obesity, type 2 diabetes, and hypertension.

Often dubbed the 'silent disease' MASLD progresses without obvious symptoms, delaying diagnosis and increasing the risk of severe complications such as liver cirrhosis, liver cancer, and cardiovascular disease.

Because it tends to develop silently over years, many individuals only discover they have MASLD when significa...